Looking Back at ARUP’s 40-Year History

“Not a lot of companies last 40 years. It’s worth marking the moment because ARUP is not just existing. We’re thriving,” said Andy Theurer, CEO. Throughout ARUP Laboratories’ 40 years, there have been many remarkable moments.

Looking Back at ARUP’s 40-Year History

“Not a lot of companies last 40 years. It’s worth marking the moment because ARUP is not just existing. We’re thriving,” said Andy Theurer, CEO. Throughout ARUP Laboratories’ 40 years, there have been many remarkable moments.



Lloyd MartinLloyd Martin 

Ernst J. Eichwald, MD, chair of the University of Utah Department of Pathology, hires Lloyd Martin as a business manager. Martin plants the seeds of a new idea: pathologists owning, operating, and expanding a reference laboratory.


John M. Matsen, III, MD, incorporates Associated Regional and University Pathologists Inc. and becomes ARUP’s first chief executive officer (CEO).


ARUP Laboratories launches. Lab staffers receive pink slips from the University of Utah Hospital and immediately join the new company at 390 Wakara Way in Research Park. Exterior of a building


Intermountain Healthcare becomes an ARUP client.


ARUP moves to 500 Chipeta Way. Designed by Russ Haymond and Charles DeWitt, the 75,000-square-foot building is constructed in 10 months. Exterior of a building


John M. Matsen

Matsen becomes University of Utah vice president of health sciences, and Carl R. Kjeldsberg, MD, is named president and CEO of ARUP.


Ronald Weiss, MD, MBA, is named director of laboratories. He helps translate ARUP’s vision and mission statements into The Five Pillars of ARUP Culture. ARUP's vision statement on a wall


Responsibility for operational logistics shifts from medical directors to technical operations managers. Labs are staffed 24/7/365 to better meet patients’ and clients’ needs.


Carl T. Wittwer, MD, PhD, and K. Owen Ash, PhD, lead ARUP as it offers the first polymerase chain reaction (PCR) test and jumps into molecular pathology.


Building 2 is added. Kjeldsberg, Matsen, and University of Utah President Arthur K. Smith, PhD, cut the ribbon. Three men cit a large purple ribbon


The ARUP Institute for Clinical and Experimental Pathology® is founded under the direction of Harry R. Hill, MD.


William L. “Bill” Roberts, MD, PhD, joins ARUP. He is instrumental in forming the Children’s Health Improvement through Laboratory Diagnostics (CHILDxTM) program and initiating ARUP’s pediatric reference interval study.


ARUP exits the corporate drug testing business. Drug testing adThis image and tagline were used on ARUP’s drug testing brochure.


Lab stewardship is introduced with the Analyzing Test Ordering PatternsTM (ATOP®) report.


Building 3 is added and gives ARUP an additional 72,000 square feet of space. ARUP acquires a nucleic acid sequencer, which enables the development of the original Hepatitis C Virus Genotype test. Workers in hardhats in front of a large window


ARUP obtains tax-exempt status.


ARUP’s Institute for Learning is established to provide educational opportunities to employees and clients.


Kjeldsberg and University of Utah President Bernie Machen, DDS, MS, PhD, shake on a deal that ARUP is not for sale. Within months, their deal falls apart when Machen seriously entertains a bid from Sorenson Capital. Two men shake handsKjeldsberg and Machen agree ARUP is not for sale.


ARUP volunteers use of its lab facilities to the doping control lab of the University of California, Los Angeles (UCLA), which performs athlete drug testing during the Winter Olympics in Salt Lake City.


The deal with Sorenson Capital is called off. Kjeldsberg agrees to give the university more control over ARUP and 5% of annual revenue.


ARUP launches a year-long initiative to expand newborn screening under Utah state law by utilizing a new mass spectrometry method that allows for simultaneous analysis for multiple newborn diseases.


ARUP’s Building 1.5 opens with the world’s largest lab specimen freezer, a two-story, 7,000-square-foot unit that can hold 2.2 million specimens and has fully robotic storage and retrieval capabilities. Interior shot of the freezer


Weiss becomes company president and chief operating officer.


Charles D. Hawker, PhD, MBA, spearheads implementation of a new lab automation system that can transport and sort up to 4,000 specimens an hour.


ARUP Consult® launches as a clinician test selection guide to share expertise beyond the lab. It was originally designed for Palm Pilots.


ARUP opens an on-site childcare center. A child plays on a daycare playground


ARUP Consultative Services begins offering market opportunity assessments, outreach infrastructure evaluation, and outreach business planning.


ARUP purchases a building at 560 Arapeen Drive. The Transportation Department moves to a new airport facility.


ARUP Blood Services opens a 15,000-square-foot facility in Sandy, Utah. Kjeldsberg retires. Edward R. “Ed” Ashwood, MD, becomes ARUP’s president and third CEO.


ARUP expands its no-cost employee clinic into a fully staffed Family Health Clinic. A doctor with a patient


ARUP assumes testing oversight for the University of Utah community clinics and South Jordan laboratories.


Under Hawker’s guidance, ARUP implements the MagneMover LITE automation track system to move specimens through the lab at 2 meters per second, which enables ARUP to manage 7,000 specimens an hour. An automation track system


Dean Li, MD, PhD, serves as ARUP’s interim CEO.


Edgar Braendle, MD, PhD, becomes CEO.


Sherrie L. Perkins, MD, PhD, is named CEO and becomes the first woman CEO of a major reference laboratory in the United States. Andy Theurer is named president after serving as chief financial officer (CFO).


ARUP earns International Organization for Standardization (ISO) 15189 status from the College of American Pathologists (CAP). Hawker coauthors a report detailing ARUP’s 25-year journey toward achieving the prestigious Six Sigma score for lost specimens.


ARUP partners with Techcyte Inc. to develop the world’s first artificial intelligence (AI)-augmented ova and parasite detection tool, which sets the stage for expansion of digital diagnostics. ARUP's AI-augmented ova-and-parasite detection tool


On March 12, ARUP begins molecular diagnostic testing for COVID-19 under the leadership of Chief Medical Officer (CMO) Julio Delgado, MD. In September, Delgado transitions into an executive vice president role, and Tracy George, MD, is named CMO. On November 7, ARUP verifies its 1 millionth COVID-19 result.


Andy Theurer Andy Theurer is named CEO after more than 30 years with the company. George is named president and continues in her role as CMO.


Outside shot of building 4 ARUP opens its newest building, Building 4. Every aspect of the new building has been carefully designed to optimize large-scale laboratory operations and position ARUP for future growth.


Jonathan Genzen, MD, PhD, is named CMO, and Adam Barker, PhD, becomes chief operations officer (COO). Consultative Services is rebranded as ARUP Healthcare Advisory Services. Jonathan Genzen and Jonathan Genzen


The ARUP Institute for Research and Innovation in Diagnostic and Precision MedicineTM (R&I Institute) is formed under the direction of George, chief scientific officer and president of the Innovation Business Unit.


ARUP earns FDA approval for AAV5 DetectCDxTM, a first-ever companion diagnostic immunoassay for a gene therapy.


ARUP’s University Business Unit is created, led by President Dan Albertson, MD.